Search results for "pero"

showing 10 items of 3365 documents

Inflammation et immunité : implications dans l’obésité et le diabète de type 2

2006

The evidences have been increasingly accumulated on the implication of inflammatory mediators like tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the pathological states related to insulin resistance like obesity, type 2 diabetes and atherosclerosis. There seems a link between insulin resistance and these pro-inflammatory agents, secreted by macrophages and adipocytes. Th (helper) cells are differentiated into either Th1 or Th2 phenotypes. It is generally considered that Th1 phenotype is pro-inflammatory whereas Th2 phenotype exerts anti-inflammatory (protective) effects. The upregulation of Th1 phenotype may aggravate these pathologies. One of the adipokines, i.e., adiponectin…

medicine.medical_specialtyobesitymedicine.medical_treatmentPeroxisome proliferator-activated receptorInflammationlcsh:TP670-699BiologyBiochemistryPPARfatty acidsInsulin resistanceDownregulation and upregulationInternal medicinemedicinechemistry.chemical_classificationAdiponectinInsulinmedicine.diseaseInsulin receptorimmune systemEndocrinologyCytokinechemistryinflammationImmunologybiology.proteinmedicine.symptomlcsh:Oils fats and waxesFood ScienceOléagineux, Corps gras, Lipides
researchProduct

Inhibition of the NF-κB Signaling Pathway Mediates the Anti-inflammatory Effects of Petrosaspongiolide M

2003

Petrosaspongiolide M (PT) is a potent secretory phospholipase A(2) inhibitor and anti-inflammatory agent. This marine metabolite reduced the production of nitrite, prostaglandin E(2), and tumor necrosis factor-alpha in the mouse air pouch injected with zymosan. These effects were also observed in mouse peritoneal macrophages stimulated with zymosan. Inhibition of these inflammatory mediators was related to reductions in inducible nitric oxide synthase, cyclo-oxygenase-2, and tumor necrosis factor-alpha expression. Since nuclear factor-kappaB (NF-kappaB) appears to play a central role in the transcriptional regulation of these proteins by macrophages, we investigated the effects of PT on thi…

medicine.medical_treatmentAnti-Inflammatory AgentsNitric Oxide Synthase Type IIBiochemistryDinoprostoneMicechemistry.chemical_compoundPhospholipase A2NF-KappaB Inhibitor alphaCell MovementmedicineAnimalsRNA MessengerOleanolic AcidPhosphorylationNitritesPharmacologybiologyTumor Necrosis Factor-alphaZymosanNF-kappa BZymosanBiological TransportNF-κBDNACell biologyIsoenzymesNitric oxide synthaseIκBαCytokinechemistryBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesModels AnimalMacrophages Peritonealbiology.proteinCytokinesI-kappa B ProteinsTumor necrosis factor alphaNitric Oxide SynthaseSignal TransductionProstaglandin E
researchProduct

MYOCARDIAL POTENCY OF AQUEOUS EXTRACT OF HARUNGANA MADAGASCARIENSIS STEM BARK AGAINST ISOPROTERENOL-INDUCED MYOCARDIAL DAMAGE IN RATS

2018

Objectives: The present study was undertaken to evaluate the effects of Harungana madagascariensis on electrocardiographical, biochemical and histopathological changes in isoproterenol (ISO)-induced myocardial infarction in rats. Methods: Male Wistar albino rats were randomly divided and treated with the aqueous extract of Harungana madagascariensis stem bark (AEHM, 200 and 400 mg/kg per os), or normal saline or vitamin E for 7 days with concomitant administration of ISO (85 mg/kg, subcutaneously) on 8th and 9th days, at 24 h interval. Results: The ISO injections to the rats caused cardiac dysfunction evidenced by a marked (P<0.01) elevation in ST-segment, a reduction in R wave amplitude (P…

medicine.medical_treatmentCardiac marker01 natural sciencesLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineLactate dehydrogenasemedicineHarungana[CHIM]Chemical SciencesPotencyComputingMilieux_MISCELLANEOUSbiologyTraditional medicinebusiness.industryVitamin E[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesMalondialdehydebiology.organism_classification030205 complementary & alternative medicine0104 chemical sciences3. Good health010404 medicinal & biomolecular chemistrychemistryFlacourtia indicabusinessUniversal Journal of Pharmaceutical Research
researchProduct

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

2002

Abstract In a previous study, we reported a new pyrroloquinazoline derivative, 3-(4′-acetoxy-3′,5′-dimethoxy)benzylidene-1,2-dihydropyrrolo[2,1- b ]quinazoline-9-one (PQ), which inhibited human purified 5-lipoxygenase activity and prostaglandin E 2 release in lipopolysaccharide-stimulated RAW 264.7 cells. In the present work, we show that PQ inhibits cyclo-oxygenase-2 activity in intact cell assays (human monocytes) and purified enzyme preparations (ovine isoenzymes) without affecting cyclo-oxygenase-1 activity. This behaviour was confirmed in vivo by using the zymosan-injected mouse air pouch model, where PQ caused a marked reduction in cell migration and leukotriene B 4 levels at 4 h, as …

medicine.medical_treatmentPharmacologyMonocytesMicechemistry.chemical_compoundIn vivomedicineAnimalsEdemaHumansCyclooxygenase InhibitorsPyrrolesLipoxygenase InhibitorsEnzyme InhibitorsProstaglandin E2Pain MeasurementPharmacologyAnalgesicsArachidonate 5-LipoxygenaseSheepCyclooxygenase 2 InhibitorsDose-Response Relationship DrugbiologyChemistryAnti-Inflammatory Agents Non-SteroidalZymosanMembrane ProteinsBiological activityIsoenzymesBiochemistryMechanism of actionCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesEnzyme inhibitorArachidonate 5-lipoxygenaseQuinazolinesQuinolinesbiology.proteinFemalemedicine.symptomProstaglandin Emedicine.drug
researchProduct

Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins.

2004

Recruitment and activation of polymorphonuclear neutrophils (PMNs) reflects a primary immunological response to invading pathogens and has also emerged as a hallmark of vascular inflammation. One of the principal enzymes released upon PMN activation is myeloperoxidase (MPO), a heme protein that not only generates cytotoxic oxidants but also impacts deleteriously on nitric oxide-dependent signaling cascades within the vasculature. Because MPO also associates with the membrane of PMN, we evaluated whether MPO could also function as an autocrine modulator of PMN activation. The extent of PMN membrane-associated MPO was elevated in patients with acute inflammatory vascular disease compared with…

medicine.medical_treatmentanimal diseasesCD18p38 Mitogen-Activated Protein KinasesCell DegranulationNeutrophil ActivationProinflammatory cytokinechemistry.chemical_compoundSuperoxidesmedicineHumansPhosphorylationPeroxidaseMultidisciplinaryCD11b AntigenbiologySuperoxideElastaseDegranulationNF-kappa Bhemic and immune systemsBiological SciencesMolecular biologyCytokineIntegrin alpha MchemistryMyeloperoxidaseCD18 AntigensImmunologybiology.proteinProceedings of the National Academy of Sciences of the United States of America
researchProduct

Hyperosmolar therapy for acute brain injury: study protocol for an umbrella review of meta-analyses and an evidence mapping

2020

Introduction Acute brain injury is a challenging public health problem worldwide. Elevated intracranial pressure is a common complication after acute brain injury. Hyperosmolar therapy is one of the main therapeutic strategies for the management of intracranial hypertension. This study protocol outlines an umbrella review of meta-analyses which will investigate the benefits and harms of hyperosmolar therapy routinely used for the management of acute brain injury in the intensive care. Methods and analysis We will search PubMed/MEDLINE, EMBASE and the Cochrane Database of Systematic Reviews. We will include meta-analyses of primary research studies (eg, randomised controlled trials, observat…

meta-analysilaw.inventionAnaesthesia0302 clinical medicineHypertonic salinesystematic reviewlawBrain Injuries TraumaticProtocolMedicineMannitol1506030212 general & internal medicineBrain injuryRandomized Controlled Trials as TopicEvidence-Based MedicineRGeneral MedicineIntensive care unit3. Good healthTreatment OutcomeSystematic reviewResearch DesignMeta-analysisMedicinehyperosmolar therapy1682medicine.medical_specialtyCritical CareMEDLINE03 medical and health sciencesMeta-Analysis as TopicIntensive careHumansHyperosmolar therapyCerebral perfusion pressureIntensive care medicineSaline Solution HypertonicDroitbusiness.industrymannitolbrain injuryHypertonic salinemeta-analysisMeta-analysisSystematic reviewFluid TherapyObservational studyIntracranial Hypertensionbusiness030217 neurology & neurosurgeryhypertonic saline
researchProduct

Exosomal HSP60 levels and related miRNAs in brain tumors

In cancer, Extracellular Vesicles (EVs), such as exosomes, contribute to tumor progression by regulating local and systemic parameters. Since exosomes are released into body fluids, they may be used in nanomedicine as a valuable source of diagnostic biomarkers. The prognosis of brain tumors is poor even after surgical resection followed by post-operatory chemo- and radio-therapies and it is cogent to find innovative treatments. The discovery that molecular chaperones can be determinant factors in tumorigenesis and the increasing understanding of exosomes, particularly in what refers to their release by tumor cells and contents, including chaperones and miRNA, provide elements to develop nov…

molecular chaperones HSP60 exosomes brain tumor new therapeutic tools.
researchProduct

The molecular anatomy of human Hsp60 and its effects on Amyloid-β peptide

Heat Shock Protein 60 (HSP60) is ubiquitous and highly conserved, being present in eukaryotes and prokaryotes, including pathogens. This chaperonin is typically considered a mitochondrial protein but it is also found in other intracellular sites, extracellularly and in circulation. HSP60 is an indispensable component of the Chaperoning System and plays a key role in protein quality control, preventing off-pathway folding events and refolding misfolded proteins. This makes HSP60 a putative therapeutic agent for neurodegenerative diseases associated with aggregation of misfolded proteins, for example, Alzheimer’s Disease. We produced and purified recombinant human HSP60 and investigated the e…

molecular chaperones Heat Shock Protein 60kDa neurodegenerative diseaseSettore BIO/16 - Anatomia Umana
researchProduct

Tolerance, Adaptation, and Cell Response Elicited by Micromonospora sp. Facing Tellurite Toxicity: A Biological and Physical-Chemical Characterization

2022

The intense use of tellurium (Te) in industrial applications, along with the improper disposal of Te-derivatives, is causing their accumulation in the environment, where oxyanion tellurite (TeO32&minus;) is the most soluble, bioavailable, and toxic Te-species. On the other hand, tellurium is a rare metalloid element whose natural supply will end shortly with possible economic and technological effects. Thus, Te-containing waste represents the source from which Te should be recycled and recovered. Among the explored strategies, the microbial TeO32&minus; biotransformation into less toxic Te-species is the most appropriate concerning the circular economy. Actinomycetes are ideal candidates in…

multivariate statistical analysisExtracellular Polymeric Substance MatrixSuperoxide DismutaseOrganic ChemistryGeneral MedicineSettore BIO/19 - Microbiologia Generalefatty acidsMicromonosporaCatalysisComputer Science ApplicationsInorganic ChemistryFTIR spectroscopyProtein Aggregatestellurite; bacterial cell membrane; cell morphology changes; fatty acids; FTIR spectroscopy; oxidative stress; heavy metals; multivariate statistical analysisbacterial cell membranecell morphology changesoxidative stressPhysical and Theoretical ChemistryTelluriumheavy metalstelluriteMolecular BiologySpectroscopy
researchProduct

Physiactisome: A New Nanovesicle Drug Containing Heat Shock Protein 60 for Treating Muscle Wasting and Cachexia.

2022

Currently, no commercially available drugs have the ability to reverse cachexia or counteract muscle wasting and the loss of lean mass. Here, we report the methodology used to develop Physiactisome&mdash;a conditioned medium released by heat shock protein 60 (Hsp60)&mdash;overexpressing C2C12 cell lines enriched with small and large extracellular vesicles. We also present evidence supporting its use in the treatment of cachexia. Briefly, we obtain a nanovesicle-based secretion by genetically modifying C2C12 cell lines with an Hsp60-overexpressing plasmid. The secretion is used to treat na&iuml;ve C2C12 cell lines. Physiactisome activates the expression of PGC-1&alpha; isoform 1, which is di…

muscle atrophyProteomicsCachexiaexerciseArticle ; cachexia ; muscle atrophy ; exercise ; exosome ; muscle wasting ; sarcopeniamuscle wastingGeneral MedicineChaperonin 60ddc:sarcopeniaMuscular Atrophycachexia; muscle atrophy; exercise; exosome; muscle wasting; sarcopeniaQuality of LifeexosomeHumanscachexia; exercise; exosome; muscle atrophy; muscle wasting; sarcopeniaMuscle SkeletalCells
researchProduct